Zobrazeno 1 - 10
of 139
pro vyhledávání: '"David, Pryor"'
Autor:
Natalie Plant, Adam Mylonas, Chandrima Sengupta, Doan Trang Nguyen, Shona Silvester, David Pryor, Peter Greer, Yoo Young (Dominique) Lee, Prabhakar Ramachandran, Venkatakrishnan Seshadri, Yuvnik Trada, Richard Khor, Tim Wang, Nicholas Hardcastle, Paul Keall
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background This observational study aims to establish the feasibility of using x-ray images of radio-opaque chemoembolisation deposits in patients as a method for real-time image-guided radiation therapy of hepatocellular carcinoma. Methods
Externí odkaz:
https://doaj.org/article/07eeac21a75e4b139fd0edf1eebed5d1
Autor:
Alan Wigg, Jonathan Tibballs, Richard Woodman, Katherine Stuart, Hien Le, Stuart K. Roberts, John K. Olynyk, Simone I. Strasser, Michael Wallace, Jarad Martin, Annette Haworth, Nicholas Hardcastle, Kee Fong Loo, Colin Tang, Yoo Young Lee, Julie Chu, Richard De Abreu Lourenco, Adam Koukourou, Diederick De Boo, Kate McLean, Jackie Buck, Rohit Sawhney, Amanda Nicoll, Anouk Dev, Marnie Wood, Alicia Braund, Martin Weltman, Richard Khor, Miriam Levy, Tim Wang, Michael Potter, James Haridy, Ashok Raj, Oliver Duncan, Amany Zekry, Natalie Collier, James O’Beirne, Catherine Holliday, Yuvnik Trada, Jaw Tronidjaja, Jacob George, David Pryor
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Therapeutic options for early-stage hepatocellular carcinoma (HCC) in individual patients can be limited by tumor and location, liver dysfunction and comorbidities. Many patients with early-stage HCC do not receive curative-intent
Externí odkaz:
https://doaj.org/article/6d523d1c82814f78b6224ff1b323717f
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Background and purposeThe purpose of this study was to assess the dosimetric improvements achieved in prostate stereotactic body radiotherapy (SBRT) treatment within the PROMETHEUS and NINJA trials using an in-house real-time position monitoring syst
Externí odkaz:
https://doaj.org/article/04a1c061bbbe4fae915074af8c39e4e1
Long term cost outcomes among commercially insured patients undergoing bariatric surgical procedures
Publikováno v:
Obesity Science & Practice, Vol 10, Iss 1, Pp n/a-n/a (2024)
Abstract Objective Bariatric procedures have become safer in recent years, warranting new data on long‐term costs. This study examined the impact of bariatric procedures on a person's long‐term healthcare costs up to 10 years and if it differed b
Externí odkaz:
https://doaj.org/article/ff6327653956477ea81288b2243090bf
Autor:
Ashika D. Maharaj, John Lubel, Eileen Lam, Paul J. Clark, Oliver Duncan, Jacob George, Gary P. Jeffrey, Lara Lipton, Howard Liu, Geoffrey McCaughan, Eu‐Ling Neo, Jennifer Philip, Simone I. Strasser, Katherine Stuart, Alexander Thompson, Jonathan Tibballs, Thomas Tu, Michael C. Wallace, Alan Wigg, Marnie Wood, Amany Zekry, Elysia Greenhill, Liane J. Ioannou, Golo Ahlenstiel, Kaye Bowers, Stephen J. Clarke, Anouk Dev, Michael Fink, Mark Goodwin, Christos S. Karapetis, Miriam T. Levy, Kate Muller, James O'Beirne, David Pryor, James Seow, Nicholas Shackel, Caroline Tallis, Nick Butler, John K. Olynyk, Kate Reed‐Cox, John R. Zalcberg, Stuart K. Roberts
Publikováno v:
Hepatology Communications, Vol 6, Iss 11, Pp 3260-3271 (2022)
Abstract Although there are several established international guidelines on the management of hepatocellular carcinoma (HCC), there is limited information detailing specific indicators of good quality care. The aim of this study was to develop a core
Externí odkaz:
https://doaj.org/article/9a7c14322e6647adba6c1e30e2bfeb06
Autor:
Kee Fong Loo, Richard J Woodman, Damjana Bogatic, Vidyaleha Chandran, Kate Muller, Mohamed Asif Chinnaratha, John Bate, Kirsty Campbell, Matthew Maddison, Sumudu Narayana, Hien Le, David Pryor, Alan Wigg
Publikováno v:
JGH Open, Vol 6, Iss 9, Pp 599-606 (2022)
Abstract Background and Aim The rate of contraindications to percutaneous ablation (PA) for inoperable early hepatocellular carcinoma (HCC) and subsequent outcomes is not well described. We investigated the prevalence and outcomes of inoperable early
Externí odkaz:
https://doaj.org/article/acdd0fd29ae14e5f84caba52ec6c83b7
Autor:
Muhammad Ali, Simon Wood, David Pryor, Daniel Moon, Mathias Bressel, Arun A. Azad, Catherine Mitchell, Declan Murphy, Homi Zargar, Nick Hardcastle, Jamie Kearsley, Renu Eapen, Lih Ming Wong, Katharine Cuff, Nathan Lawrentschuk, Paul J. Neeson, Shankar Siva
Publikováno v:
Contemporary Clinical Trials Communications, Vol 33, Iss , Pp 101145- (2023)
Background: Surgery remains the standard of care for localised renal cell carcinoma (RCC). Nevertheless, nearly 50% of patients with high-risk disease experience relapse after surgery, with distant sites being common. Considering improved outcomes in
Externí odkaz:
https://doaj.org/article/4d0e507036ae41018c85cc8e525fcedc
Autor:
Elizabeth A. Connolly, Vivek A. Bhadri, Johnathon Wake, Katrina M. Ingley, Jeremy Lewin, Susie Bae, Daniel D. Wong, Anne P. Long, David Pryor, Stephen R. Thompson, Madeleine C. Strach, Peter S. Grimison, Annabelle Mahar, Fiona Bonar, Fiona Maclean, Angela Hong
Publikováno v:
Cancer Medicine, Vol 11, Iss 8, Pp 1805-1816 (2022)
Abstract CIC‐rearranged sarcoma is a recently established, ultra‐rare, molecularly defined sarcoma subtype. We aimed to further characterise clinical features of CIC‐rearranged sarcomas and explore clinical management including systemic treatme
Externí odkaz:
https://doaj.org/article/809b318996414281bb0f72c0b212b5e1
Autor:
Nicholas Hardcastle, Olivia Cook, Xenia Ray, Alisha Moore, Kevin L. Moore, David Pryor, Alana Rossi, Farshad Foroudi, Tomas Kron, Shankar Siva
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-10 (2021)
Abstract Introduction Quality assurance (QA) of treatment plans in clinical trials improves protocol compliance and patient outcomes. Retrospective use of knowledge-based-planning (KBP) in clinical trials has demonstrated improved treatment plan qual
Externí odkaz:
https://doaj.org/article/d960450ddd774588be42f100da30814e
Autor:
Yoo Young Dominique Lee, Doan Trang Nguyen, Trevor Moodie, Ricky O’Brien, Anne McMaster, Andrew Hickey, Nicole Pritchard, Per Poulsen, Elizaveta Mitkina Tabaksblat, Britta Weber, Esben Worm, David Pryor, Julie Chu, Nicholas Hardcastle, Jeremy Booth, Val Gebski, Tim Wang, Paul Keall
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Stereotactic Ablative Body Radiotherapy (SABR) is a non-invasive treatment which allows delivery of an ablative radiation dose with high accuracy and precision. SABR is an established treatment for both primary and secondary liver
Externí odkaz:
https://doaj.org/article/588e637bf4f3437a99165c6bbd9612f4